It has been known for many years that mRNA molecules are decorated with a large number of distinct chemical modifications. In recent years, enzymes, which catalyse and remove these modifications from mRNA molecules have been identified and characterized. The research field called ‘epitranscriptomics’, which studies the impact of these dynamic mRNA modifications on mRNA homeostasis and regulation of gene expression is currently a very hot topic in biology. One particularly important mRNA modification is N6-methyladenosine (m6A).
Researchers in the lab of Michiel Vermeulen, together with colleagues in Nijmegen, Munich and Chicago, performed a global mass spectrometry-based interaction screening for m6A readers in various cell types and mRNA sequence contexts. Their data reveals that YTH proteins are conserved and cell-type independent m6A readers. In addition, they identified a number of sequence context dependent m6A readers, including FMR1, thus linking m6A to regulation of mRNA translation and fragile X-linked mental retardation. Strikingly, their data also revealed that many proteins have a clear preference for unmodified versus m6A containing mRNA. One such repelled protein is G3BP1, a known stress granule protein. Subsequent RNA sequencing and proteomics experiments revealed that G3BP1 and FMR1 regulate m6A-linked mRNA stability and translation rates, respectively. In summary, these experiments have revealed an intricate interplay between m6A readers and repelled proteins and various aspects of mRNA homeostasis.
This work was recently published in the prestigious journal Nature Structural and Molecular Biology.
Related news items

T cell immunity is directed by tetraspanin CD53
5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read more
A single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta
21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read more
Dutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read more
European grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant
26 April 2022The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.
read more
Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation published in Cellular and Molecular Life Sciences
20 April 2022 Lisa Huis in ‘t Veld, Nataschja Ho and colleagues from the team of Gosse Adema published in Cellular and Molecular Life Sciences that Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation. read more
Rubicon grants awarded to three RIMLS researchers
19 April 2022Three researchers have received Rubicon funding from NWO/ZonMw. This will enable Elke Muntjewerff, Laura de Vries and Laurens van de Wiel to do research at a foreign research institute for the next two years.
read more